141 related articles for article (PubMed ID: 2144998)
41. [Value of peritoneal cytology after hysteroscopy in endometrial adenocarcinoma stage I].
Levêque J; Goyat F; Dugast J; Loeillet L; Grall JY; Le Bars S
Contracept Fertil Sex; 1998 Dec; 26(12):865-8. PubMed ID: 9923115
[TBL] [Abstract][Full Text] [Related]
42. Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus?
Saga Y; Imai M; Jobo T; Kuramoto H; Takahashi K; Konno R; Ohwada M; Suzuki M
Gynecol Oncol; 2006 Oct; 103(1):277-80. PubMed ID: 16678244
[TBL] [Abstract][Full Text] [Related]
43. Molecular characterization and significance for prognosis of free gastric cancer cells in the peritoneal cavity.
Li C; Ma Y; Xue Y; Zhang H; Wei Y
Hepatogastroenterology; 2009; 56(91-92):891-8. PubMed ID: 19621724
[TBL] [Abstract][Full Text] [Related]
44. High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy.
Sonoda Y; Zerbe M; Smith A; Lin O; Barakat RR; Hoskins WJ
Gynecol Oncol; 2001 Mar; 80(3):378-82. PubMed ID: 11263935
[TBL] [Abstract][Full Text] [Related]
45. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
[TBL] [Abstract][Full Text] [Related]
46. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
47. Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas.
Meszoely IM; Lee JS; Watson JC; Meyers M; Wang H; Hoffman JP
Am Surg; 2004 Mar; 70(3):208-13; discussion 213-4. PubMed ID: 15055843
[TBL] [Abstract][Full Text] [Related]
48. Image analysis of cellular DNA content in peritoneal fluid of patients with ovarian tumors of low malignant potential and invasive epithelial ovarian cancer.
Guidozzi F; Szumel RC; Ball JH; Johnston DA; Katz RL; Kidd L
Gynecol Oncol; 1996 May; 61(2):204-9. PubMed ID: 8626133
[TBL] [Abstract][Full Text] [Related]
49. Influence of positive peritoneal cytology on prognostic factors and survival in early-stage endometrial cancer: a systematic review and meta-analysis.
Lee B; Suh DH; Kim K; No JH; Kim YB
Jpn J Clin Oncol; 2016 Aug; 46(8):711-7. PubMed ID: 27207885
[TBL] [Abstract][Full Text] [Related]
50. Peritoneal cytology in endometrial carcinoma.
Sutton GP
Cancer Treat Res; 1989; 49():41-52. PubMed ID: 2577201
[TBL] [Abstract][Full Text] [Related]
51. Malignant potential of positive peritoneal cytology in endometrial cancer.
Hirai Y; Takeshima N; Kato T; Hasumi K
Obstet Gynecol; 2001 May; 97(5 Pt 1):725-8. PubMed ID: 11339924
[TBL] [Abstract][Full Text] [Related]
52. Peritoneal fluid cytology in endometrial cancer: its significance and the role of chromic phosphate (32P) therapy.
Heath R; Rosenman J; Varia M; Walton L
Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):815-22. PubMed ID: 3182321
[TBL] [Abstract][Full Text] [Related]
53. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease.
Kadar N; Homesley HD; Malfetano JH
Gynecol Oncol; 1992 Aug; 46(2):145-9. PubMed ID: 1500014
[TBL] [Abstract][Full Text] [Related]
54. Peritoneal cytology in stage I endometrial cancer.
Hernandez E; Rosenshein NB; Dillon MB; Villar J
J Natl Med Assoc; 1985 Oct; 77(10):799-803. PubMed ID: 4057270
[TBL] [Abstract][Full Text] [Related]
55. Peritoneal cytology in endometrial cancer: a review.
McLellan R; Dillon MB; Currie JL; Rosenshein NB
Obstet Gynecol Surv; 1989 Oct; 44(10):711-9. PubMed ID: 2677857
[TBL] [Abstract][Full Text] [Related]
56. Peritoneal cytology in malignant mixed müllerian tumors of the uterus.
Kanbour AI; Buchsbaum HJ; Hall A; Kanbour AI
Gynecol Oncol; 1989 Apr; 33(1):91-5. PubMed ID: 2539314
[TBL] [Abstract][Full Text] [Related]
57. Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals.
Creasman WT; Disaia PJ; Blessing J; Wilkinson RH; Johnston W; Weed JC
Am J Obstet Gynecol; 1981 Dec; 141(8):921-9. PubMed ID: 7315922
[TBL] [Abstract][Full Text] [Related]
58. Peritoneal cytology in endometrial carcinoma.
Ito K; Inoue Y; Obata K; Noda K
Tohoku J Exp Med; 1992 Mar; 166(3):387-94. PubMed ID: 1585348
[TBL] [Abstract][Full Text] [Related]
59. [Hysteroscopy: its value in the pretherapeutic evaluation of endometrial adenocarcinomas].
Martel P; Toufik L
J Gynecol Obstet Biol Reprod (Paris); 1991; 20(2):216-20. PubMed ID: 2071866
[TBL] [Abstract][Full Text] [Related]
60. [Living cytology in the diagnosis of malignant ovarian tumor].
Tanaka Y; Ueda G; Hiramatsu K; Inoue Y; Saito J; Nishino T; Sato Y; Yamasaki M; Inoue M; Kurachi K
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jul; 35(7):934-8. PubMed ID: 6875345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
